Original Research

Clinical Investigation of the Efficacy and Safety of Anlotinib with Immunotherapy in Advanced Non-Small Cell Lung Cancer as Third-Line Therapy: A Retrospective Study

Yang S, Zhang W, Chen Q, Guo Q

Cancer Management and Research 2020, 12:10333-10340

Published Date: 19 October 2020